I suspect this popular medicine has been the target of a discrediting campaign for the simple reason it competes with newer, far more expensive blood thinners and pain relievers that cost much more. STORY AT-A-GLANCE There was a massive discrediting propaganda campaign hurled at aspirin by Big Pharma fifty years ago when it came out with expensive and dangerous non-steroidal anti-inflammatories (NSAIDs).
Aspirin is a staple medicine that is frequently recommended as a remedy to control inflammation and prevent blood clots. It could have helped limit the pandemic death toll, had it not been downplayed and ignored.
According to research published in April 2021, aspirin reduced COVID-19 patients’ need for mechanical ventilation by 44 percent, ICU admission by 43 percent, and mortality by 47 percent.
Proteolytic enzymes like lumbrokinase, serrapeptase, and nattokinase are safer and perhaps even superior choices to aspirin for their anti-clot properties. These enzymes, when taken on an empty stomach, act as natural anticoagulants by breaking down fibrin.
Proteolytic enzymes may also be helpful for long-COVID. Researchers have found that people who die from COVID-19 have extensive lung damage caused by persistent virus-infected cells that cause scar formation. Proteolytic enzymes can help dissolve this scar tissue, as fibrin is a primary component. Aspirin (acetylsalicylic acid) was introduced in 1899 as an alternative to sodium salicylate,1 a pain reliever and anti-inflammatory known for its unpleasant side effects such as stomach cramps, heartburn, nausea, and vomiting. It’s been a staple medicine in most households ever since and is frequently recommended as a remedy to control inflammation and prevent blood clots that can lead to stroke and heart attack….